Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A low grade childhood congenital malignant neoplasm arising from the kidney. It is characterized by the presence of fibroblastic cells. The majority of cases occur in the first year of life. Complete excision is usually associated with an excellent prognosis.
Biomarker and diagnostic research for congenital mesoblastic nephroma has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
58 publications have been identified in PubMed for congenital mesoblastic nephroma. Research spans Case Report / Case Series (29%), Review / Meta-Analysis (21%), and Basic Science / Preclinical (21%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 | 29% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 11:56 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
11 |
21% |
Laboratory research | 11 | 21% |
Testing and diagnosis research | 6 | 12% |
Disease patterns and progression | 5 | 10% |
Other research | 2 | 4% |
Clinical study results | 2 | 4% |
Cantoni C (2026). [PMID: 41899513](https://pubmed.ncbi.nlm.nih.gov/41899513/). *Cancers (Basel)*. [Review / Meta-Analysis]
van de Vondervoort S (2026). [PMID: 41718596](https://pubmed.ncbi.nlm.nih.gov/41718596/). *Ned Tijdschr Geneeskd*. [Case Report / Case Series]
Ortiz MV (2026). [PMID: 41478859](https://pubmed.ncbi.nlm.nih.gov/41478859/). *Nat Rev Urol*. [Review / Meta-Analysis]
Bosoteanu M (2026). [PMID: 42018497](https://pubmed.ncbi.nlm.nih.gov/42018497/). *Am J Case Rep*. [Case Report / Case Series]
Lockow S (2026). [PMID: 41265286](https://pubmed.ncbi.nlm.nih.gov/41265286/). *J Comp Pathol*. [Case Report / Case Series]
Hughes K (2026). [PMID: 42073152](https://pubmed.ncbi.nlm.nih.gov/42073152/). *Children (Basel)*. [Epidemiology / Natural History]
Quarello P (2026). [PMID: 42189790](https://pubmed.ncbi.nlm.nih.gov/42189790/). *PLoS One*. [Epidemiology / Natural History]
Bischoff AC (2026). [PMID: 41032745](https://pubmed.ncbi.nlm.nih.gov/41032745/). *Cancer Res*. [Basic Science / Preclinical]
Rathod G (2026). [PMID: 42003167](https://pubmed.ncbi.nlm.nih.gov/42003167/). *Curr Pediatr Rev*. [Diagnostic / Biomarker]
Li J (2026). [PMID: 41810180](https://pubmed.ncbi.nlm.nih.gov/41810180/). *Transl Pediatr*. [Epidemiology / Natural History]